Market Position Centrafarm's longstanding presence of over 60 years in the Dutch generics and biosimilars market positions it as a trusted provider with deep industry experience, offering opportunities to expand its portfolio and market reach.

Parent Company Advantage As part of the global STADA network, Centrafarm benefits from extensive resources and distribution channels, enabling sales teams to leverage international connections for introducing new products or expanding into adjacent markets.

Product Portfolio Specializing in high-quality generics, biosimilars, and branded medicines, Centrafarm presents opportunities to align with healthcare providers seeking affordable, reliable medication options, boosting potential sales through partnership.

Technology Stack Utilizing diverse tech tools such as MySQL, JSON-LD, and ASP.NET indicates a modern infrastructure, providing avenues for offering digital health solutions, data management services, or tech-enhanced pharmaceutical products.

Growth & Revenue With revenues estimated between 1 and 10 million dollars and a relatively compact team of 70 employees, there is scalability potential for sales efforts aimed at mid-sized healthcare firms and distributors seeking innovative generics and biosimilars.